![Shui On Leung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shui On Leung
Vorstandsvorsitzender bei
SINOMAB BIOSCIENCE LIMITED
Vermögen: 21 Mio $ am 31.05.2026
Profil
Shui On Leung is the founder of Sinomab Bioscience Ltd. since 2001, holding the title of Chairman & Chief Executive Officer.
Current job includes serving as Director at Hong Kong Genome Institute.
Former jobs include Associate Director-Molecular Biology Department at Immunomedics, Inc. from 1991 to 2000, Managing Director at The Hong Kong Institute of Biotechnology Ltd. from 2000 to 2003, and Director at Novelmab Ltd. from 2011 to 2018.
Education includes a doctorate from the University of Oxford conferred in 1989, an undergraduate degree from The Chinese University of Hong Kong conferred in 1984, a graduate degree from The Chinese University of Hong Kong conferred in 1986, and an MBA from The Chinese University of Hong Kong conferred in 2006.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SINOMAB BIOSCIENCE LTD. 9,36 % | 15.08.2025 | 129 729 200 ( 9,36 % ) | 21 Mio $ | 31.05.2026 |
Aktive Positionen von Shui On Leung
| Unternehmen | Position | Beginn |
|---|---|---|
| SINOMAB BIOSCIENCE LIMITED | Vorstandsvorsitzender | 01.01.2003 |
Hong Kong Genome Institute | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Shui On Leung
| Unternehmen | Position | Ende |
|---|---|---|
Novelmab Ltd. | Direktor/Vorstandsmitglied | 01.07.2018 |
The Hong Kong Institute of Biotechnology Ltd. | Vorstandsvorsitzender | 01.08.2003 |
| IMMUNOMEDICS, INC. | Corporate Officer/Principal | 01.07.2000 |
Ausbildung von Shui On Leung
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
96
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Chinese University of Hong Kong
 The Chinese University of Hong Kong Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hong Kong Institute of Biotechnology Ltd. | |
Sinomab Bioscience Ltd.
 Sinomab Bioscience Ltd. BiotechnologyHealth Technology Manufactures and distributes antibodies | Health Technology |
Novelmab Ltd. | |
Hong Kong Genome Institute |
